Top Pharmaceutical Companies in Los Angeles, CA (79)
GoodRx is America’s healthcare marketplace. Each month, millions of people visit goodrx.com to find reliable health information and discounts for their healthcare — and we’ve helped people save $35 billion since 2011. We provide prescription discounts that are accepted at more than 70,000 pharmacies in the U.S., as well as telehealth services including doctor visits and lab tests. Our goal is...
GoodRx's Top Stability & Growth Strengths
Product Line Growth: Newer businesses such as Pharma Direct and subscriptions are expanding rapidly, with clear momentum highlighted in 2026. Investment is being shifted toward these lines to replace slower legacy revenue.
Future-Ready Strategy: Management is prioritizing Pharma Direct and subscription products and raised 2026 revenue guidance, signaling a transition aimed at restoring overall growth. These segments are described as the main engines expected to offset declines in the legacy business.
Profitability: Profitability remains solid even as the top line fluctuates, including positive GAAP earnings and substantial adjusted EBITDA in Q2 2026. Operating cash flow also strengthened, supporting continued execution.
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
ALS Limited is a global leader in testing, inspection, certification, and verification services, providing comprehensive solutions across industries such as life sciences, minerals, industrial, and energy.
ALS Limited's Top Stability & Growth Strengths
Strong Revenue Growth: Financial results highlight record revenue with double‑digit year‑on‑year increases, supported by organic expansion and acquisitions. Growth has been broad-based across the portfolio with standout momentum in the Commodities division.
Profitability: Earnings expanded faster than sales, with underlying profit and margins rising to new highs. Momentum includes strong EBIT growth and accelerating NPAT alongside ongoing business transformations.
Strong Market Position & Advantage: Positioning as a top‑tier global specialist—especially in minerals and environmental testing—supports commercial resilience. A large international laboratory network and recognized expertise (including PFAS capabilities) underpin competitive strength.
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than any...
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of cell and exosome-based therapeutics. Its lead product candidate, Deramiocel, is an allogeneic cell therapy currently in late-stage clinical development for the treatment of Duchenne muscular dystrophy (DMD). The company also leverages its proprietary StealthX™ exosome platform for the targeted delivery of therapeutic agents to treat...
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from...
Amerita, Inc. is a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost-effective delivery settings, a growing bio-pharmaceutical pipeline of
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
PDC Pharmacy is a long-term care pharmacy that provides specialized pharmaceutical services for individuals with intellectual disabilities, autism, and behavioral health needs, exclusively serving provider agencies.
Obagi Cosmeceuticals is a specialty pharmaceutical company that develops, markets and sells, and is the leading provider of proprietary topical aesthetic and therapeutic clinically-proven skin care systems in the physician-dispensed market. The systems are designed to prevent and improve the most common and visible skin disorders. The foundation of the company began in 1988 with the creation of the Obagi...
Authentica Media is a creative, full-service video storytelling agency specializing in the healthcare sector, specifically for MedTech and Pharma marketers. The agency collaborates with leading healthcare brands to create clinically accurate, human-centric video content that strengthens connections between brands, clinicians, and patients. Their mission is to make complex medical stories clear and accessible, ultimately helping patients find the medical innovations...
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.
RDI Trials is a tech-enabled Contract Research Organization (CRO) specializing in In Vitro Diagnostics (IVD) development. They offer end-to-end services, including sourcing samples and managing clinical trials to help IVD manufacturers obtain FDA clearance.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is a leading nonprofit research organization focused on biomedical innovation, translating discovery into health impact through research, education, and community outreach.
We are alchemists at heart, harnessing science to create powerful wellness solutions. The combination of alchemy and “me” offers the right mixture of science, expertise, and support that empowers our customers with confidence. Through one-of-a-kind expert-designed formulas and positive guidance, Alchemee provides solutions that are as effective as they are transformative. At Alchemee, we are committed to empowering the world one person at a...
Clínica Monseñor Oscar A. Romero is a 501(c)(3) nonprofit Federally Qualified Health Center (FQHC) dedicated to providing quality, affordable, and culturally sensitive healthcare to underserved communities in greater Los Angeles. The clinic offers medical, dental, vision, pharmacy, and behavioral health services regardless of a patient's ability to pay, while honoring the legacy and teachings of Monseñor Oscar A. Romero.
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
PolyPeptide is a global Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of peptide-based active pharmaceutical ingredients (APIs) and oligonucleotides. Serving pharmaceutical and biotech customers worldwide, the company supports the creation of therapies for metabolic diseases, cancer, and neurological disorders, contributing to the health of millions of patients through deep technical expertise and GMP-quality production.
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions....
Indegene's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyst assessments place the company in leadership cohorts for life sciences commercial AI/analytics and digital services for commercial operations, indicating defensible positioning in its specialization. The company is also described as a best-fit provider for digital commercialization, omnichannel activation, content operations at scale, and AI-driven commercial analytics, reinforcing category leadership within that lane.
Strong Revenue Growth: Revenue shows clear acceleration into FY26, including a strong year-over-year increase in the latest reported quarter and a positive exit rate from prior quarters as deal wins converted. Full-year FY25 results also show year-over-year growth alongside continued profitability, supporting an upward growth trajectory.
Product Line Growth: Capability expansion is evidenced by recent acquisitions intended to deepen data-driven omnichannel, media offerings, and consulting/transformation coverage, broadening the commercialization toolkit. Ongoing scaling post-IPO is also framed as broadening capabilities beyond prior scope within its core focus areas.
